Apr. 24 at 3:45 PM
$MAT🚨🚨 WAKE UP — this setup is getting too obvious to ignore! 🚨🚨
We’re sitting near
$3.10, and the 1-year analyst price target is
$16.00 — that’s a projected +416% upside 📈
Rating? Strong Buy — no confusion, no debate. This is a conviction play.
Last week’s move was just the beginning — we’re hearing high-confidence info from private sources:
⚠️ Major upside expected early next week — 100%+ move very much in play.
And yes, the sources are legit.
Microfloat, FDA catalyst, confirmed revenue, big-name partners (Thermo Fisher, Quest), and now?
📊 Analyst targets that scream undervalued.
🦍 I’m calling all
$EXPE $VIAV apes — you’ve seen what coordinated action can do.
Hold off and drop your orders together — coordinated buys = max impact 💥
Let’s ignite this. Eyes on the breakout. Next week won’t wait. 🔥🚀
Not financial advice. But ignoring this? Might cost more than missing a trade.
